The potential therapeutic effects of THC on Alzheimer’s disease

Protein Misfolding, Functional Amyloid, and Human Disease

Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,497

Forecasting the global burden of Alzheimer's disease

Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370

The molecular logic of endocannabinoid signalling

Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957

Epidemiology of Alzheimer disease

Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675

Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470

GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,211

The GSK3 hypothesis of Alzheimer’s disease

Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191

Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & CEBALLOS, M. L. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 801

Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase

Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., & Anderton, B. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90774-2 · Cited by 737

Cannabinoid CB2Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains

Benito, C., Núñez, E., Tolón, R. M., Carrier, E. J., Rábano, A., Hillard, C. J., & Romero, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11136.2003 · Cited by 636

Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells

Lovestone, S., Reynolds, C. H., Latimer, D. A., Davis, D. R., Anderton, B. H., Gallo, J., Hanger, D. P., Mulot, S., Marquardt, B., Stabel, S., et al. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00246-3 · Cited by 473

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease

Rich, J. B., Rasmusson, D. X., Folstein, M. F., Carson, K. A., Kawas, C., & Brandt, J. (1995) · Neurology · doi:10.1212/wnl.45.1.51 · Cited by 446

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer’s Disease

Martín-Moreno, A. M., Reigada, D., Ramírez, B. G., Mechoulam, R., Innamorato, N. G., Cuadrado, A., & CEBALLOS, M. L. D. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071290 · Cited by 410

GSK3 and tau: Two convergence points in Alzheimer’s disease

Hernandez, F., Lucas, J. J., & Avila, J. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129025 · Cited by 359

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study

Núñez, E., Benito, C., Pazos, M. R., Barbáchano, A., Fajardo, O., González, S. R., Tolón, R. M., & Romero, J. (2004) · Synapse · doi:10.1002/syn.20050 · Cited by 346

Glycogen Synthase Kinase 3β Phosphorylates Tau at Both Primed and Unprimed Sites

Cho, J.-H., & Johnson, G. V. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206236200 · Cited by 266

Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study

Ashton, J. C., Friberg, D., Darlington, C. L., & Smith, P. F. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.038 · Cited by 224

Chronic lithium administration to FTDP‐17 tau and GSK‐3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre‐formed neurofibrillary tangles do not revert

Engel, T., Goñi‐Oliver, P., Lucas, J. J., Avila, J., & Hernández, F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04139.x · Cited by 223

Cannabinoid Function in Learning, Memory and Plasticity

Riedel, G., & Davies, S. N. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_15 · Cited by 219

Caffeine and Coffee as Therapeutics Against Alzheimer's Disease

Arendash, G. W., & Cao, C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091249 · Cited by 209

Caffeine Suppresses Amyloid-β Levels in Plasma and Brain of Alzheimer's Disease Transgenic Mice

Cao, C., Cirrito, J. R., Lin, X., Wang, L., Verges, D. K., Dickson, A., Mamcarz, M. B., Zhang, C., Mori, T., Arendash, G. W., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1071 · Cited by 198

Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia

Walther, S., Mahlberg, R., Eichmann, U., & Kunz, D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0343-1 · Cited by 190

Prototype Alzheimer’s Disease Vaccine Using the Immunodominant B Cell Epitope from β-Amyloid and Promiscuous T Cell Epitope Pan HLA DR-Binding Peptide

Agadjanyan, M. G., Ghochikyan, A., Petrushina, I., Vasilevko, V., Movsesyan, N., Mkrtichyan, M., Saing, T., & Cribbs, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1580 · Cited by 186

Melatonin treatment restores mitochondrial function in Alzheimer’s mice: a mitochondrial protective role of melatonin membrane receptor signaling

Dragicevic, N., Copes, N., O’Neal-Moffitt, G., Jin, J., Buzzeo, R. W., Mamcarz, M., Tan, J., Cao, C., Olcese, J., Arendash, G. W., et al. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00864.x · Cited by 185

Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease

DaRocha-Souto, B., Coma, M., Pérez-Nievas, B. G., Scotton, T. C., Siao, M., Sánchez-Ferrer, P., Hashimoto, T., Fan, Z., Hudry, E., Barroeta, I., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.002 · Cited by 180

Aβ Toxicity in Alzheimer's Disease

Cavallucci, V., D’Amelio, M., & Cecconi, F. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8251-3 · Cited by 179

Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100

Sun, X., Sato, S., Murayama, O., Murayama, M., Park, J.-M., Yamaguchi, H., & Takashima, A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02583-6 · Cited by 161

Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders

Bisogno, T., & Marzo, V. D. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793361568 · Cited by 159

Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments

Ishiguro, K., Omori, A., Takamatsu, M., Sato, K., Arioka, M., Uchida, T., & Imahori, K. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90839-y · Cited by 151

High Blood Caffeine Levels in MCI Linked to Lack of Progression to Dementia

Cao, C., Loewenstein, D., Lin, X., Zhang, C., Wang, L., Duara, R., Wu, Y., Giannini, A., Bai, G., Cai, J., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111781 · Cited by 135

Alzheimer's disease; taking the edge off with cannabinoids?

Campbell, V. A., & Gowran, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707446 · Cited by 132

Reversible effects of acute and long-term administration of Δ-9-tetrahydrocannabinol (THC) on memory in the rat

Nakamura, E. M., da Silva, E. A., Concilio, G. V., Wilkinson, D. A., & Masur, J. (1991) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(91)90072-7 · Cited by 110

Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis

Marchalant, Y., Brothers, H. M., Norman, G. J., Karelina, K., DeVries, A. C., & Wenk, G. L. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.014 · Cited by 103

GSK3 and p53 - is there a link in Alzheimer's disease?

Proctor, C. J., & Gray, D. A. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-7 · Cited by 80

Cannabinoids and neuroprotection in CNS inflammatory disease

Jackson, S. J., Diemel, L. T., Pryce, G., & Baker, D. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.002 · Cited by 70

GSK3α exhibits β‐catenin and tau directed kinase activities that are modulated by Wnt

Asuni, A. A., Hooper, C., Reynolds, C. H., Lovestone, S., Anderton, B. H., & Killick, R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05243.x · Cited by 64

Tetrahydrocurcumin confers protection against amyloid β-induced toxicity

Mishra, S., Mishra, M., Seth, P., & Sharma, S. K. (2010) · Neuroreport · doi:10.1097/wnr.0b013e328341e141 · Cited by 61

The Amyloid Peptide and Its Precursor in Alzheimer's Disease

Octave, J. N. (1995) · Reviews in the Neurosciences · doi:10.1515/revneuro.1995.6.4.287 · Cited by 34

Facts and figures

Foxell, S. (2014) · doi:10.4324/9781315857510-19 · Cited by 22

Bioenergetics breakdown in Alzheimer's disease: targets for new therapies.

Saxena, U. (2011) · PubMed · Cited by 18

Molecular Mechanisms, Emerging Etiological Insights and Models to Test Potential Therapeutic Interventions in Alzheimers Disease

Pillay, N., Kellaway, L. A., & Kotwal, G. J. (2004) · Current Alzheimer Research · doi:10.2174/1567205043331965 · Cited by 7

Untitled work

(1997) · doi:10.1002/(sici)1099-1166(199709)12:9

BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease

Moussa‐Pacha, N. M., Abdin, S. M., Omar, H. A., Alniss, H., & Al‐Tel, T. H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21622 · Cited by 274

Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science

Baron, E. P. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 268

Endocannabinoid system in neurodegenerative disorders

Basavarajappa, B. S., Shivakumar, M., Joshi, V., & Subbanna, S. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14098 · Cited by 222

CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease

Liguori, C., Stefani, A., Sancesario, G., Sancesario, G., Marciani, M. G., & Pierantozzi, M. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308577 · Cited by 162

Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review

Cooray, R., Gupta, V. B., & Suphioglu, C. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02054-6 · Cited by 146

Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer's disease

Cao, C. (2022) · Digital Commons - University of South Florida (University of South Florida)

An ultra-low dose of Δ9-tetrahydrocannabinol improves Alzheimer’s Disease-related cognitive deficitsPreprint

Nitzan, K., Ellenbogen, L., Beniamin, T., Sarne, Y., & Doron, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.22.457252 · Cited by 1

A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology

Eubanks, L. M., Rogers, C. J., Beuscher, Koob, G. F., Olson, A. J., Dickerson, T. J., & Janda, K. D. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060066m · Cited by 270

Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice

Wang, Y., Hong, Y., Yan, J., Brown, B., Lin, X., Zhang, X., Shen, N., Li, M., Cai, J., Gordon, M. N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052757 · Cited by 24

Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice

Aso, E., Sánchez-Pla, A., Vegas-Lozano, E., Maldonado, R., & Ferrer, I. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141014 · Cited by 154